Skip to main content
. 2024 Mar 4;16(5):1041. doi: 10.3390/cancers16051041
CTLA-4 cytotoxic T-lymphocyte–associated antigen 4
PD-1 programmed death 1
PD-L1 programmed cell death-ligand 1
IDO indoleamine 2,3-dioxygenase
NK natural killer
irAEs immune-related adverse events
A adenine
U uracil
G guanine
C cytosine
dU deoxyuridine
PBMCs peripheral blood mononuclear cells
LDH lactate dehydrogenase